Dimension Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dimension Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.57M	Buy	27,959 +2,633	+10%	+$329K	0.5%	31
2025 Q4	$3.09M	Sell	25,326 -2,290	-8%	-$263K	0.43%	35
2025 Q3	$2.77M	Sell	27,616 -306	-1%	-$27.6K	0.4%	36
2025 Q2	$2.32M	Hold	27,922	–	–	0.36%	36
2025 Q1	$2.26M	Buy	27,922 +10,635	+62%	+$951K	0.4%	28
2024 Q4	$1.56M	Buy	17,287 +767	+5%	+$74.3K	0.25%	37
2024 Q3	$1.63M	Buy	16,520 +1,209	+8%	+$119K	0.3%	36
2024 Q2	$1.42M	Buy	15,311 +3,396	+29%	+$304K	0.29%	35
2024 Q1	$1.13M	Buy	11,915 +2,827	+31%	+$262K	0.23%	39
2023 Q4	$811K	Hold	9,088	–	–	0.17%	44
2023 Q3	$664K	Hold	9,088	–	–	0.16%	37
2023 Q2	$756K	Hold	9,088	–	–	0.16%	43
2023 Q1	$693K	Hold	9,088	–	–	0.16%	45
2022 Q4	$754K	Sell	9,088 -11,738	-56%	-$950K	0.18%	45
2022 Q3	$1.65M	Sell	20,826 -3,518	-14%	-$297K	0.4%	31
2022 Q2	$1.81M	Buy	24,344 +3,069	+14%	+$230K	0.41%	29
2022 Q1	$1.91M	Buy	+21,275	New	+$1.96M	0.36%	34

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimension Capital Management's XBI Position: Q1 2026 in Review

Dimension Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 10% in Q1 2026, buying an estimated $329K and bringing the position to 27,959 shares worth $3.57M. The position accounts for 0.5% of the portfolio, ranked #31.

Dimension Capital Management first reported a position in XBI in Q1 2022 and has held it in 17 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Dimension Capital Management held 27,959 shares of State Street SPDR S&P Biotech ETF worth $3.57M as of Q1 2026.
Dimension Capital Management bought 2,633 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $329K.
State Street SPDR S&P Biotech ETF made up 0.5% of Dimension Capital Management's portfolio in Q1 2026, its #31 holding.
Dimension Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 17 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Dimension Capital Management's 13F filing for Q1 2026, filed 15 May 2026.